B of A Securities Maintains Buy on HUTCHMED (China), Lowers Price Target to $17

Benzinga Newsdesk www.benzinga.com Negative 44.5%

Neg 44.5% Neu 0% Pos 0%

B of A Securities analyst Alec Stranahan maintains HUTCHMED (China) (NASDAQ:HCM) with a Buy and lowers the price target from $20 to $17.